PA Medical News about Teicoplanin Vancomycin

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Use of Antiemetic Agents in Acute Gastroenteritis

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: A retrospective chart review
Clinical Therapeutics, 10/29/09

Hung Y–P et al. – Based on this retrospective chart review of hospitalized patients with vancomycin–induced fever, rash, or neutropenia, only 10% experienced subsequent teicoplanin–induced fever, rash, or neutropenia. However, it should be noted that half of the patients with vancomycin–induced neutropenia developed teicoplanin–induced neutropenia.